Neurodegenerative actions of interleukin-1 in the rat brain are mediated through increases in seizure activity

The cytokine interleukin‐1 (IL‐1) is an established and important mediator of diverse forms of neuronal injury in experimental animals. However, its mechanisms of action remain largely unknown. We have reported previously that IL‐1 markedly enhances excitotoxic injury induced in the rat by striatal...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of neuroscience research Vol. 83; no. 3; pp. 385 - 391
Main Authors:	Patel, H.C., Ross, F.M., Heenan, L.E., Davies, R.E., Rothwell, N.J., Allan, S.M.
Format:	Journal Article
Language:	English
Published:	Hoboken Wiley Subscription Services, Inc., A Wiley Company 15-02-2006
Subjects:	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - toxicity Analysis of Variance Animals Anticonvulsants - therapeutic use Cell Count - methods cell death Cell Death - drug effects Corpus Striatum - drug effects Corpus Striatum - pathology Corpus Striatum - physiopathology cytokines Diazepam - administration & dosage Diazepam - therapeutic use Disease Models, Animal Drug Interactions Electroencephalography - methods epilepsy excitotoxicity Immunohistochemistry - methods inflammation Interleukin-1 - toxicity Male Nerve Degeneration - drug therapy Nerve Degeneration - etiology Proto-Oncogene Proteins c-fos - metabolism Rats Rats, Sprague-Dawley Seizures - complications Seizures - drug therapy Time Factors
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The cytokine interleukin‐1 (IL‐1) is an established and important mediator of diverse forms of neuronal injury in experimental animals. However, its mechanisms of action remain largely unknown. We have reported previously that IL‐1 markedly enhances excitotoxic injury induced in the rat by striatal administration of the excitotoxin α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionate (AMPA), leading to widespread neuronal loss throughout the ipsilateral cortex. Here we tested the hypothesis that IL‐1 causes this injury through induction and/or enhancement of seizure activity in the rat. Consistently with this hypothesis, intrastriatal injection of AMPA or AMPA with IL‐1 in the rat brain increased c‐Fos expression in regions similar to those in which c‐Fos has been reported previously in response to seizures. A significant increase in cortical neuronal activity (number of c‐Fos positive cells) was observed in response to AMPA with IL‐1 compared with AMPA (8 hr after injection). Increased seizure duration [3,522 ± 660 sec (SEM) vs. 1,415 ± 301 sec; P < 0.001] and cell death volume (140 ± 20 mm3 vs. 52 ± 6 mm3; P < 0.001) were seen in response to coinfusion of AMPA with IL‐1 vs. AMPA alone. In addition, the anticonvulsant diazepam (intraperitoneal) significantly reduced cell death (P < 0.001) and seizure duration (P < 0.001) induced by AMPA with IL‐1, and a significant correlation was found between seizure duration and cell death volume. These findings support our hypothesis that IL‐1 enhances excitotoxic injury by enhancement of seizures, which may be of relevance to IL‐1 actions in other forms of neuronal injury, including cerebral ischemia. © 2005 Wiley‐Liss, Inc.
Bibliography:	ArticleID:JNR20735 istex:5D6BB5417B1E7F8BB9F036E7ED9A13F16BAC72F1 Medical Research Council ark:/67375/WNG-DR56MZ6V-N
ISSN:	0360-4012 1097-4547
DOI:	10.1002/jnr.20735